Press Room
  Date Title View
Aug 10, 2017
FOSTER CITY, Calif., Aug. 10, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) (the "Company" or "SciClone") today announced the expiration on August 6, 2017 of the 60 day "go-shop" period provided for under the terms of the previously announced Agreement and Plan of Merger (the "Merger Agreement") between the Company and a consor...
PDF
Aug 9, 2017
FOSTER CITY, Calif., Aug. 9, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended June 30, 2017. Revenues: In the second quarter of 2017, SciClone reported revenues of $44.5 million, compared to $39.0 million for the same period in 2016. GAAP Diluted EPS: In the seco...
PDF
Jun 8, 2017
FOSTER CITY, Calif., June 8, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) (the "Company" or "SciClone") and a consortium consisting of entities affiliated with GL Capital Management GP Limited ("GL Capital"), Bank of China Group Investment Limited ("BOCGI"), CDH Investments, Ascendent Capital Partners and Boying (collectively,...
PDF
May 10, 2017
FOSTER CITY, Calif., May 10, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended March 31, 2017. Revenues: In the first quarter 2017, SciClone reported revenues of $42.9 million, compared to $36.5 million for the same period in 2016. GAAP Diluted EPS: In the first q...
PDF
May 4, 2017
FOSTER CITY, Calif., May 4, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the first quarter 2017 on Wednesday, May 10, 2017. SciClone will host a conference call and webcast to provide a business update at 4:30 pm ET (1:30 pm PT) that day. The call will be hosted by ...
PDF
Mar 27, 2017
FOSTER CITY, Calif., March 27, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Wilson W. Cheung, Chief Financial Officer, will present a corporate overview and business update at the 16th Annual Needham Healthcare Conference at 5:00 pm ET on Tuesday, April 4, 2017, at the Westin NY Grand Central Hotel in New ...
PDF
Mar 6, 2017
FOSTER CITY, Calif., March 6, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the fourth quarter and year ended December 31, 2016. Revenues: In the fourth quarter of 2016, SciClone reported revenues of $44.1 million, compared to $42.9 million for the same period in 2015. Revenues fo...
PDF
Feb 21, 2017
FOSTER CITY, Calif., Feb. 21, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the fourth quarter and full year 2016 on Monday, March 6, 2017. SciClone will host a conference call and webcast to provide a business update at 8:30 am ET (5:30 am PT) that day. The call wil...
PDF
Feb 1, 2017
FOSTER CITY, Calif., Feb. 1, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview and business update at the 19th Annual BIO CEO & Investor Conference at 4:30 pm ET on Monday, February 13, 2017, at the Waldorf Astoria Hotel in New ...
PDF
Nov 14, 2016
FOSTER CITY, Calif., Nov. 14, 2016 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) ("SciClone") today confirmed that it has received an unsolicited, nonbinding proposal from a consortium led by GL Capital Management GP Limited and ABG Management Limited to acquire all of the outstanding shares of SciClone not already owned by the cons...
PDF
1
...
NextLast